The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 20, 2021
Filed:
Dec. 06, 2016
Applicant:
University of Utah Research Foundation, Salt Lake City, UT (US);
Inventors:
Balamurali K. Ambati, Sandy, UT (US);
Hironori Uehara, Salt Lake City, UT (US);
Santosh Muddana, Salt Lake City, UT (US);
Assignee:
University of Utah Research Foundation, Salt Lake City, UT (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/34 (2006.01); A61K 9/00 (2006.01); A61P 27/02 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 31/198 (2006.01); A61K 31/525 (2006.01); A61K 31/352 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 33/34 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 31/198 (2013.01); A61K 31/525 (2013.01); A61P 27/02 (2018.01); A61K 31/352 (2013.01);
Abstract
An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.